NHS Framework Agreement - National Generic Pharmaceutical Products - Interim
key details
| Value | £12,107,466 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West |
| Deadline | 23 Jan 2019 |
| Contract start | 1 Aug 2019 |
| Contract end | 28 Feb 2021 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-6c13eb97-94e8-4d42-9491-e4bb08a5f0d9 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Please see list of awarded suppliers (including SME status) at t | £12,107,466 | 30 Apr 2019 | active |
description
Framework agreement for NHS National Generic Pharmaceuticals - Interim
Offer reference number: CM/PHG/18/5574
Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 38 months Potential periods of call-offs under the framework agreement:
Oral Products:
All Regions 01/08/2019 to 28/02/2021 (19 months)
Hospital Only Products:
LSNE 01/08/2019 to 31/01/2020 (6 months)
NWLN 01/08/2019 to 31/01/2020 (6 months)
CESW 01/08/2019 to 31/01/2020 (6 months)
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 2 Jul 2019 | Award (award) | · | ae58e067-084f-4f09-847c-5387f230aaac-298773 |
more from NHS England
- Market Engagement Event for East ofEngland prisons · £0 · 11 Sept 2026
- Finance Transformation & Enablement Project Support · £7,944,879 · 10 Sept 2026
- Provision of Public Consultation and Engagement Services for the UISPC · £155,000 · 8 Sept 2026
- Targeted Lung Health Checks National Licences · £1,900,000 · 8 Sept 2026
- Adult Screening and Personalisation Digital Delivery Services · £215,163,316 · 4 Sept 2026
- Step into the NHS - Schools Programme · £65,800 · 2 Sept 2026
- Website hosting and support for hee.nhs.uk and healthcareers.nhs.uk · £168,336 · 1 Sept 2026
- NHS Login Run and Maintain 2 · £30,000,000 · 28 Aug 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.